Stage 20: Brain Optimization Technology
Concept 4 of 4
L20.4

Digital Cognitive Training

Lumosity to BrainHQ — what actually transfers, what doesn't.

Warm cream-tinted manuscript page, deep slate margin annotations, electric-blue palette. Digital cognitive training — Lumosity, BrainHQ, CogniFit, the consumer market. Margin clusters on what actually transfers to real-world function and what does not.

Digital cognitive training — Lumosity, BrainHQ, CogniFit, and dozens of competitors — has been one of the most extensively marketed cognitive interventions of the past two decades. The evidence picture has evolved through cycles of overclaiming, FTC corrective action (the Lumosity settlement in 2016 addressed deceptive advertising), and continued research that has identified specific applications where benefit is reasonable. The clinical task is to recommend evidence-based applications appropriately while declining to endorse the broader marketed claims.

The transfer question is central. Patients improve on the specific tasks they train on — virtually universally. The clinically meaningful question is whether the improvement transfers to real-world cognitive function (memory, attention, executive function in daily life). Some training programs show transfer to closely-related tasks; far transfer to unrelated cognitive domains and real-world function is more limited. The training that does not transfer to real-world function is not a meaningful clinical intervention.

BrainHQ has the strongest evidence base. Developed by Posit Science with substantial research foundation. The ACTIVE trial showed maintained improvement in cognitive function and reduced dementia incidence at 10-year follow-up. The Speed of Processing Training has the most robust evidence; other modules have varying levels of support. BrainHQ for cognitively-healthy older adults and patients with MCI has meaningful evidence; the recommendation is reasonable in these populations. Lumosity and other consumer programs have weaker evidence. The 2016 FTC settlement addressed claims unsupported by adequate research. Some Lumosity tasks have legitimate cognitive engagement value; the broader claims about transfer and dementia prevention are not adequately supported.

The clinical scenarios where digital training is reasonable. MCI patients engaging cognitive engagement work — particularly BrainHQ-style adaptive training. Cognitively-healthy older adults wanting structured cognitive engagement. Patients with specific attention or processing-speed concerns where targeted training may help. Stroke or TBI rehabilitation in combination with broader cognitive rehabilitation. The training is one component of cognitive engagement, alongside reading, learning new skills, social engagement, and physical exercise.

The longevity-psychiatry framework. Cognitive training is part of the cognitive engagement work that supports cognitive reserve (Stage 8). The largest single intervention for cognitive trajectory is exercise (Stage 9); cognitive engagement adds incrementally. Real-world cognitive engagement (learning new skills, complex social interaction, demanding work or volunteer activities) likely provides as much or more benefit than digital training. The training is reasonable adjunct; it is not the dominant cognitive optimization intervention. The discipline is to recommend digital training where evidence supports use (BrainHQ in MCI, structured cognitive engagement in interested patients), redirect attention to real-world cognitive engagement and the broader Modifiable Twelve prescription, and decline to endorse marketed claims that exceed evidence.

Editorial illustration of the transfer question — improvement on trained tasks versus improvement in real-world cognitive function. The central empirical question that determines whether training is meaningful intervention.
The anchor

Digital cognitive training has variable evidence; BrainHQ (Posit Science) has strongest evidence including ACTIVE trial 10-year dementia incidence reduction. Transfer to real-world function is the central question. Reasonable adjunct; not dominant cognitive optimization intervention. Exercise and real-world cognitive engagement matter more.

Painterly editorial illustration of programs with meaningful evidence — BrainHQ-style adaptive training in MCI populations, the specific cognitive domains where transfer occurs, the realistic recommendations versus the marketed claims.
Prove it

A 65-year-old patient with MCI (recently diagnosed) asks about cognitive training apps. She is engaged in addressing modifiable risk factors and wants to know which app to use. How do you advise?

This connects to

Locked concepts unlock as you reach them on the path.

Back